glp 1 and pulmonary embolism GLP-1 Therapies May Benefit MPN MDS Patients Potential Use of GLP-1 and

Perez-Torres, I., Guarner-Lans, V

guidance from healthcare professionals improves safety and ensures injections target appropriate muscle or subcutaneous tissue

Its potential is vast, which is precisely why understanding the optimal research protocol is so important

It is therefore clear that currently available GLP-1RAs, mimicking on the peripheral action of GLP-1 (7-36) NH2 , not only ignore the yet unknown physiology of GLP-1 (9-36) NH2 or its metabolites, but they also fail to address the tissue specific physiology of GLP-1 (7-36) NH2 , while pushing to supra-physiological limits the endocrine GLP-1 receptor axis, likely explaining the reported side-effects and only partial success in the treatment of T2D